α-Synuclein (61-95) (human) trifluoroacetate salt结构式
|
常用名 | α-Synuclein (61-95) (human) trifluoroacetate salt | 英文名 | α-Synuclein (61-95) (human) trifluoroacetate salt |
---|---|---|---|---|
CAS号 | 154040-19-4 | 分子量 | 3260.61 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 2937.7±65.0 °C at 760 mmHg | |
分子式 | C141H235N39O49 | 熔点 | N/A | |
MSDS | 美版 | 闪点 | 1730.4±34.3 °C |
用途α-Synuclein (61-95) (human) 是 α-突触核蛋白 (α-Synuclein) 的疏水核心区域,可诱导神经元细胞死亡。α-Synuclein (61-95) (human) 可用于神经退行性疾病的研究,包括阿尔茨海默病 (AD) 和帕金森病 (PD)。 |
英文名 | NAC |
---|---|
英文别名 | 更多 |
描述 | α-Synuclein (61-95) (human) 是 α-突触核蛋白 (α-Synuclein) 的疏水核心区域,可诱导神经元细胞死亡。α-Synuclein (61-95) (human) 可用于神经退行性疾病的研究,包括阿尔茨海默病 (AD) 和帕金森病 (PD)。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 2937.7±65.0 °C at 760 mmHg |
分子式 | C141H235N39O49 |
分子量 | 3260.61 |
闪点 | 1730.4±34.3 °C |
精确质量 | 3258.709473 |
LogP | -6.81 |
蒸汽压 | 0.0±0.3 mmHg at 25°C |
折射率 | 1.553 |
储存条件 | −20°C |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
Suppression of Cpn10 increases mitochondrial fission and dysfunction in neuroblastoma cells.
PLoS ONE 9(11) , e112130, (2014) To date, several regulatory proteins involved in mitochondrial dynamics have been identified. However, the precise mechanism coordinating these complex processes remains unclear. Mitochondrial chapero... |
|
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
Leuk. Lymphoma 56(3) , 739-47, (2015) The tumor suppressor p53 is often mutated in human cancers. Restoring its antitumor activity has been shown to be a promising therapeutic approach for cancer treatment. Here we analyzed the activity a... |
|
Antiviral effect of methylated flavonol isorhamnetin against influenza.
PLoS ONE 10(3) , e0121610, (2015) Influenza is an infectious respiratory disease with frequent seasonal epidemics that causes a high rate of mortality and morbidity in humans, poultry, and animals. Influenza is a serious economic conc... |
GLU-GLN-VAL-THR-ASN-VAL-GLY-GLY-ALA-VAL-VAL-THR-GLY-VAL-THR-ALA-VAL-ALA-GLN-LYS-THR-VAL-GLU-GLY-ALA-GLY-SER-ILE-ALA-ALA-ALA-THR-GLY-PHE-VAL |